Shandong Lukang Pharmaceutical Co Ltd (600789) — Financial Flexibility Index
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥68.41 Million (operating CF CN¥-6.39 Million minus capex CN¥74.80 Million) represents 0% of total liabilities (CN¥4.71 Billion). Also explore net asset momentum of Shandong Lukang Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Lukang Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Shandong Lukang Pharmaceutical Co Ltd across 28 annual periods. Check strategic asset allocation of Shandong Lukang Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Shandong Lukang Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Shandong Lukang Pharmaceutical Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | CN¥1.04 Billion | CN¥698.17 Million | CN¥4.78 Billion | ▲ +60.3% |
| 2024 | 0.14x | CN¥682.00 Million | CN¥402.82 Million | CN¥5.04 Billion | ▼ -27.2% |
| 2023 | 0.19x | CN¥941.92 Million | CN¥604.01 Million | CN¥5.06 Billion | ▲ +11.3% |
| 2022 | 0.17x | CN¥872.74 Million | CN¥444.38 Million | CN¥5.22 Billion | ▲ +15.4% |
| 2021 | 0.14x | CN¥636.07 Million | CN¥149.33 Million | CN¥4.39 Billion | ▼ -39.5% |
| 2020 | 0.24x | CN¥937.67 Million | CN¥234.55 Million | CN¥3.91 Billion | ▼ -21.2% |
| 2019 | 0.30x | CN¥1.19 Billion | CN¥361.87 Million | CN¥3.92 Billion | ▼ -11.9% |
| 2018 | 0.35x | CN¥1.21 Billion | CN¥351.09 Million | CN¥3.50 Billion | ▲ +1.4% |
| 2017 | 0.34x | CN¥1.06 Billion | CN¥275.51 Million | CN¥3.10 Billion | ▲ +11.9% |
| 2016 | 0.30x | CN¥667.75 Million | CN¥296.23 Million | CN¥2.20 Billion | ▲ +164.5% |
| 2015 | 0.11x | CN¥242.92 Million | CN¥78.39 Million | CN¥2.11 Billion | ▲ +31.0% |
| 2014 | 0.09x | CN¥226.51 Million | CN¥108.56 Million | CN¥2.58 Billion | ▼ -56.0% |
| 2013 | 0.20x | CN¥486.85 Million | CN¥256.50 Million | CN¥2.44 Billion | ▲ +18.7% |
| 2012 | 0.17x | CN¥399.60 Million | CN¥115.20 Million | CN¥2.38 Billion | ▼ -45.6% |
| 2011 | 0.31x | CN¥552.10 Million | CN¥123.28 Million | CN¥1.79 Billion | ▼ -30.5% |
| 2010 | 0.44x | CN¥599.57 Million | CN¥308.88 Million | CN¥1.35 Billion | ▲ +53.7% |
| 2009 | 0.29x | CN¥269.06 Million | CN¥199.49 Million | CN¥930.38 Million | ▲ +1.2% |
| 2008 | 0.29x | CN¥285.97 Million | CN¥209.39 Million | CN¥1.00 Billion | ▲ +86.7% |
| 2007 | 0.15x | CN¥160.54 Million | CN¥137.30 Million | CN¥1.05 Billion | ▲ +96.7% |
| 2006 | 0.08x | CN¥78.36 Million | CN¥56.24 Million | CN¥1.01 Billion | ▼ -62.0% |
| 2005 | 0.21x | CN¥222.91 Million | CN¥161.64 Million | CN¥1.09 Billion | ▲ +25.6% |
| 2004 | 0.16x | CN¥196.34 Million | CN¥63.24 Million | CN¥1.20 Billion | ▼ -49.1% |
| 2003 | 0.32x | CN¥346.67 Million | CN¥167.42 Million | CN¥1.08 Billion | ▼ -31.5% |
| 2002 | 0.47x | CN¥515.53 Million | CN¥315.59 Million | CN¥1.10 Billion | ▲ +20.3% |
| 2001 | 0.39x | CN¥473.93 Million | CN¥270.43 Million | CN¥1.22 Billion | ▲ +62.4% |
| 2000 | 0.24x | CN¥273.00 Million | CN¥22.36 Million | CN¥1.14 Billion | ▲ +26.9% |
| 1999 | 0.19x | CN¥130.69 Million | CN¥35.12 Million | CN¥691.92 Million | ▼ -59.5% |
| 1998 | 0.47x | CN¥203.14 Million | CN¥46.18 Million | CN¥435.91 Million | — |